Organization
Division of Medical Oncology & Hematology
1 abstract
Abstract
Characterization of molecular response and progression in patients with metastatic HR+/HER2- breast cancer receiving endocrine therapy and CDK4/6 inhibitors using a high-sensitivity tumor-informed assay.Org: Division of Medical Oncology & Hematology,